Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,000
Closed -$1.51M 141
2026
Q1
$1.51M Hold
20,000
0.15% 60
2025
Q4
$1.49M Hold
20,000
0.15% 62
2025
Q3
$1.35M Hold
20,000
0.14% 66
2025
Q2
$1.3M Hold
20,000
0.14% 65
2025
Q1
$1.24M Hold
20,000
0.15% 67
2024
Q4
$1.44M Hold
20,000
0.17% 64
2024
Q3
$1.63M Hold
20,000
0.19% 65
2024
Q2
$1.49M Hold
20,000
0.18% 62
2024
Q1
$1.56M Hold
20,000
0.2% 61
2023
Q4
$1.43M Hold
20,000
0.19% 63
2023
Q3
$1.39M Hold
20,000
0.2% 66
2023
Q2
$1.62M Hold
20,000
0.22% 63
2023
Q1
$1.61M Hold
20,000
0.23% 65
2022
Q4
$1.5M Hold
20,000
0.23% 54
2022
Q3
$1.29M Hold
20,000
0.21% 53
2022
Q2
$1.39M Hold
20,000
0.21% 53
2022
Q1
$1.54M Buy
+20,000
New +$1.44M 0.18% 60

Other funds holding HOLX

Sentinel Trust's HOLX Position: Q2 2026 in Review

Sentinel Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 20,000 shares — an estimated $1.51M sold.

Sentinel Trust first reported a position in HOLX in Q1 2022 and held it in 17 quarters. The position peaked at $1.63M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Sentinel Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Sentinel Trust sold 20,000 Hologic shares in Q2 2026, an estimated $1.51M.
  • Sentinel Trust first reported a position in Hologic in Q1 2022 and held it in 17 quarters.
  • Sentinel Trust's Hologic position peaked at $1.63M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.